New clinical study to be started at Ullevål University Hospital in Oslo(UUS. Impact of Medox®/MP865® on cardiovascular system. Human, randomized, double blind, placebo controlled, cross over study expected to be started early2008 and finalized in 2010.

The background for the study is results from previous studies of C3G/D3G ; Impact on hypertension and resting pulse on rats, and results from human and cell clinical studies on impact of Medox® on Chronic Inflammation(NF-KappaB and 32 other parameters; Publ Journal of  Nutrition, USA, July 2007.